A small scale study on the effects of oral administration of the β-glucan produced by Aureobasidium pullulans on milk quality and cytokine expressions of Holstein cows, and on bacterial flora in the intestines of Japanese black calves

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Uchiyama, Hirofumi ^a   Iwai, Atsushi ^a   Asada, Yukoh ^b   Muramatsu, Daisuke ^a   Aoki, Shiho ^a   Kawata, Koji ^a   Kusano, Kisato ^b   Nagashima, Koji ^c   Yasokawa, Daisuke ^c   Okabe, Mitsuyasu ^b   Miyazaki, Tadaaki ^d  

^a Aureo Science Co Ltd   (Japan)

^b Aureo Co Ltd   (Japan)

^c Hokkaido Food Processing Research Center   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; AUREOBASIDIUM PULLULANS; BACTERIA (MICROORGANISMS);

BACTERIAL DNA; BETA GLUCAN; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ASCOMYCETES; BACTERIUM; BLOOD; CATTLE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; CULTURE MEDIUM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; INTESTINE; MICROBIOLOGY; MILK; NEWBORN; ORAL DRUG ADMINISTRATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STANDARD; TIME;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ASCOMYCOTA; BACTERIA; BETA-GLUCANS; CATTLE; CLUSTER ANALYSIS; CULTURE MEDIA, CONDITIONED; CYTOKINES; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINES; MILK; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862223815     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-189     Document Type: Article

References (20)

1. The effects of beta-glucan on human immune and cancer cells. Chan GC, Chan WK, Sze DM, J Hematol Oncol 2009 2 25 10.1186/1756-8722-2-25 19515245
2. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses. Zhou LD, Zhang QH, Zhang Y, Liu J, Cao YM, Int Immunopharmacol 2009 9 4 455 462 10.1016/j.intimp.2009.01.010 19189863
3. Yeast-derived beta-glucan in combination with anti-tumor monoclonal antibody therapy in cancer. Liu J, Gunn L, Hansen R, Yan J, Recent Pat Anticancer Drug Discov 2009 4 2 101 109 10.2174/157489209788452858 19519533
4. The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation. Hetland G, Johnson E, Lyberg T, Kvalheim G, Adv Pharmacol Sci 2011 157015
5. Oral administration of paramylon, a beta-1,3-D-glucan isolated from Euglena gracilis Z inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. Sugiyama A, Hata S, Suzuki K, Yoshida E, Nakano R, Mitra S, Arashida R, Asayama Y, Yabuta Y, Takeuchi T, J Vet Med Sci 72 6 755 763
6. Ascorbic acid stimulation of production of a highly branched, beta-1,3-glucan by Aureobasidium pullulans K-1-oxalic acid, a metabolite of ascorbic acid as the stimulating substance. Hamada N, Deguchi K, Ohmoto T, Sakai K, Ohe T, Yoshizumi H, Biosci Biotechnol Biochem 2000 64 9 1801 1806 10.1271/bbb.64.1801 11055380
7. Structural characterization and solution properties of an acidic branched (1->3)-beta-D-glucan from Aureobasidium pullulans. Navarini L, Bella J, Flaibani A, Gilli R, Rizza V, Int J Biol Macromol 1996 19 3 157 163 10.1016/0141-8130(96)01121-X 8910055 (Pubitemid 26354233)
8. Structural characterisation and biological activities of a unique type beta-D-glucan obtained from Aureobasidium pullulans. Tada R, Tanioka A, Iwasawa H, Hatashima K, Shoji Y, Ishibashi K, Adachi Y, Yamazaki M, Tsubaki K, Ohno N, Glycoconj J 2008 25 9 851 861 10.1007/s10719-008-9147-3 18587644
9. Antitumor activities and immunochemical properties of the cell-wall polysaccharides from Aureobasidium pullulans. Kataoka-Shirasugi N, Ikuta J, Kuroshima A, Misaki A, Biosci Biotechnol Biochem 1994 58 12 2145 2151 10.1271/bbb.58.2145 7765709
10. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Kimura Y, Sumiyoshi M, Suzuki T, Sakanaka M, Anticancer Res 2006 26 6B 4131 4141 17201124 (Pubitemid 46031482)
11. Inhibitory effects of water-soluble low-molecular-weight beta-(1,3-1,6) d-glucan purified from Aureobasidium pullulans GM-NH-1A1 strain on food allergic reactions in mice. Kimura Y, Sumiyoshi M, Suzuki T, Suzuki T, Sakanaka M, Int Immunopharmacol 2007 7 7 963 972 10.1016/j.intimp.2007.03.003 17499199 (Pubitemid 46702846)
12. Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) enhances natural killer activity in Leishmania amazonensis-infected mice. Yatawara L, Wickramasinghe S, Nagataki M, Takamoto M, Nomura H, Ikeue Y, Watanabe Y, Agatsuma T, Korean J Parasitol 2009 47 4 345 351 10.3347/kjp.2009.47.4.345 19967081
13. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Nagashima K, Hisada T, Sato M, Mochizuki J, Appl Environ Microbiol 2003 69 2 1251 1262 10.1128/AEM.69.2.1251-1262.2003 12571054 (Pubitemid 36204859)
14. Fecal Microbiota and Improved Utility of Terminal Restriction Fragment Length Polymorphism Profiling. Nagashima K, Mochizuki J, Hisada T, Suzuki S, Shimomura K, Bioscience and Microflora 2006 25 3 99 107
15. Horizontal gene transfer in glycosyl hydrolases inferred from codon usage in Escherichia coli and Bacillus subtilis. Garcia-Vallve S, Palau J, Romeu A, Mol Biol Evol 1999 16 9 1125 1134 10.1093/oxfordjournals.molbev.a026203 10486968 (Pubitemid 29409857)
16. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K, Immunology 1989 68 1 31 36 2478449 (Pubitemid 19236065)
17. IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha. Sheron N, Williams R, Clin Exp Immunol 1992 89 1 100 103 1628417
18. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C, J Immunol 1992 149 7 2358 2366 1382099
19. Chemokines: a new classification system and their role in immunity. Zlotnik A, Yoshie O, Immunity 2000 12 2 121 127 10.1016/S1074-7613(00)80165-X 10714678 (Pubitemid 30398626)
20. Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Eyles JL, Roberts AW, Metcalf D, Wicks IP, Nat Clin Pract Rheumatol 2006 2 9 500 510 10.1038/ncprheum0291 16951705 (Pubitemid 44340426)